Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.4
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 39,505,000 $ 5,297,000
Prepaid expenses 62,000 364,000
Total Current Assets 39,567,000 5,661,000
Current liabilities    
Accounts payable 1,497,000 2,243,000
Accrued expenses 906,000 1,296,000
Accrued interest 0 4,838,000
Convertible notes payable (net of discount of $4,519,000 at December 31, 2020) 0 26,303,000
Line of Credit 31,000 31,000
Derivative liability 842,000 383,000
Total current liabilities 3,276,000 35,094,000
Stockholders' Equity (Deficit):    
Common stock, par value $0.001, 2,000,000,000 shares authorized, 28,144,077 and 5,218,122 shares issued and outstanding as of June 30, 2021 and December 31, 2020 , respectively 28,000 5,000
Common stock issuable, 3,152,000 shares at June 30, 2021 10,716,000 0
Additional paid in capital 655,655,000 566,356,000
Accumulated deficit (629,940,000) (595,628,000)
Non Controlling Interest (169,000) (169,000)
Total stockholders' equity (deficit) 36,291,000 (29,433,000)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) 39,567,000 5,661,000
Series J-1    
Stockholders' Equity (Deficit):    
Convertible Preferred stock 0 2,000
Series C    
Stockholders' Equity (Deficit):    
Convertible Preferred stock 1,000 1,000
Series K    
Stockholders' Equity (Deficit):    
Convertible Preferred stock $ 0 $ 0